Holly Evans - Concepedia

Author

Holly Evans

University of Sheffield ORCID

Also Known As

Evans, Holly R, H Evans, H. Evans, H.R. Evans, Holly Evans, Holly R Evans, Holly R. Evans, Rie Kodama, Simon Tazzyman

Publications

2.2K

Citations

H-Index

Concepts

All Affiliations

University of Sheffield Garvan Institute of Medical Research Imperial College London University of Oxford Queen Mary University of London

About

Holly Evans is an author at University of Sheffield specializing in medicine, cell biology, and osteoporosis.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	13	14	1K
2	Health Sciences	5	5	229
3	Allergy	2	2	27
4	Engineering	1	1	83
5	Allergy Medicine	1	1	15

Holly Evans

Publications

Citations

H-Index

Page 1

	Year	Citations
RETRACTED ARTICLE: The hypoxic cancer secretome induces pre-metastatic bone lesions through lysyl oxidase Thomas R. Cox, Robin M. H. Rumney, Erwin M. Schoof, Nature Redox SignalingTumor BiologyPathologyRedox BiologyRetracted Article	2015	467
LOXL2-Mediated Matrix Remodeling in Metastasis and Mammary Gland Involution Holly E. Barker, Joan Chang, Thomas R. Cox, Cancer Research	2011	247
Inhibiting Dickkopf-1 (Dkk1) Removes Suppression of Bone Formation and Prevents the Development of Osteolytic Bone Disease in Multiple Myeloma D Heath, Andrew Chantry, Clive Buckle, Journal of Bone and Mineral Research	2008	240
Inhibiting activin-A signaling stimulates bone formation and prevents cancer-induced bone destruction in vivo Andrew Chantry, Debby Heath, Aaron W. Mulivor, Journal of Bone and Mineral Research Breast Cancer MetastasesSclerostinBone ResorptionTumor MicroenvironmentBone Morphogenic Protein	2010	145
Optimal bone strength and mineralization requires the type 2 iodothyronine deiodinase in osteoblasts J. H. Duncan Bassett, A. Boyde, Peter Howell, Proceedings of the National Academy of Sciences	2010	145
Rapid-Throughput Skeletal Phenotyping of 100 Knockout Mice Identifies 9 New Genes That Determine Bone Strength J. H. Duncan Bassett, Apostolos Gogakos, Jacqueline K. White, PLoS Genetics EngineeringGeneticsOsteoporosisBone Morphogenic ProteinBone Remodeling	2012	83
Effect of the HDAC inhibitor vorinostat on the osteogenic differentiation of mesenchymal stem cells in vitro and bone formation in vivo Song Xu, Kim De Veirman, Holly Evans, Acta Pharmacologica Sinica Regenerative MedicineMesenchymal Stem CellsHdac Inhibitor VorinostatBone Morphogenic ProteinMedicine	2013	69
ER stress arm XBP1s plays a pivotal role in proteasome inhibition-induced bone formation Dan Zhang, Kim De Veirman, Rong Fan, Stem Cell Research & Therapy	2020	49
Thyroid Hormone Receptor α Mutation Causes a Severe and Thyroxine-Resistant Skeletal Dysplasia in Female Mice J. H. Duncan Bassett, A. Boyde, Tomáš Zikmund, Endocrinology Developmental BiologyShort StatureHuman GrowthMedicineGenetics	2014	48
NOD/SCID-GAMMA Mice Are an Ideal Strain to Assess the Efficacy of Therapeutic Agents Used in the Treatment of Myeloma Bone Disease Michelle A. Lawson, Julia Paton‐Hough, Holly Evans, PLoS ONE	2015	43

Page 1